Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (301-310 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 5, 2014
A new class of bispecific antibodies to redirect T cells for cancer immunotherapyDiane L Rossi, Edmund A Rossi, Thomas M Cardillo, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Mabs|February 5, 2014
NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRnJudit Cervenak, Márton Doleschall, Balázs Bender, et al.
Mabs|February 5, 2014
Consequences of glycan truncation on Fc structural integrityPatrick M Buck, Sandeep Kumar, Satish K Singh
Mabs|February 28, 2014
Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptorVictor Yip, Enzo Palma, Devin B Tesar, et al.
Mabs|March 4, 2014
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthmaE Suzanne Cohen, Claire L Dobson, Helena Käck, et al.
Mabs|March 6, 2014
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabLazaro E Aira, Alejandro López-Requena, Dasha Fuentes, et al.
Mabs|March 13, 2014
A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regionsChingwei V Lee, Patrick Koenig, Germaine Fuh
Mabs|February 1, 2014
ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasiaSophie Dupuis-Girod, Alexis Ambrun, Evelyne Decullier, et al.
Mabs|April 6, 2017
Single amino acid substitution in LC-CDR1 induces Russell body phenotype that attenuates cellular protein synthesis through eIF2α phosphorylation and thereby downregulates IgG secretion despite operational secretory pathway trafficHaruki Hasegawa, Ann Hsu, Christine E Tinberg, et al.
Pageof 184

Showing results (301-310 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 5, 2014
A new class of bispecific antibodies to redirect T cells for cancer immunotherapyDiane L Rossi, Edmund A Rossi, Thomas M Cardillo, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Mabs|February 5, 2014
NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRnJudit Cervenak, Márton Doleschall, Balázs Bender, et al.
Mabs|February 5, 2014
Consequences of glycan truncation on Fc structural integrityPatrick M Buck, Sandeep Kumar, Satish K Singh
Mabs|February 28, 2014
Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptorVictor Yip, Enzo Palma, Devin B Tesar, et al.
Mabs|March 4, 2014
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthmaE Suzanne Cohen, Claire L Dobson, Helena Käck, et al.
Mabs|March 6, 2014
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabLazaro E Aira, Alejandro López-Requena, Dasha Fuentes, et al.
Mabs|March 13, 2014
A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regionsChingwei V Lee, Patrick Koenig, Germaine Fuh
Mabs|February 1, 2014
ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasiaSophie Dupuis-Girod, Alexis Ambrun, Evelyne Decullier, et al.
Mabs|April 6, 2017
Single amino acid substitution in LC-CDR1 induces Russell body phenotype that attenuates cellular protein synthesis through eIF2α phosphorylation and thereby downregulates IgG secretion despite operational secretory pathway trafficHaruki Hasegawa, Ann Hsu, Christine E Tinberg, et al.
Pageof 184